⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11854298 | 0.84 | — | — | |
| SCHEMBL27861566 | 0.79 | — | — | |
| SCHEMBL2009418 | 0.72 | — | — | |
| SCHEMBL10478965 | 0.72 | — | — | |
| SCHEMBL26606354 | 0.72 | — | — | |
| SCHEMBL5682325 | 0.71 | ALDH1A1 (0.33) | — | |
| SCHEMBL2468757 | 0.71 | — | — | |
| SCHEMBL270060 | 0.71 | — | — | |
| SCHEMBL23512337 | 0.69 | TSHR (0.32) | — | |
| SCHEMBL11403169 | 0.69 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4277621-A1 | CRYSTALLINE BUFOTENIDINE COMPOUNDS | Caamtech, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| EP-4146799-A1 | CRYSTALLINE DIMETHYL TRYPTAMINE ANALOGUES | Caamtech, Inc. (US) | 2023-03-15 | — | — | EP | disclosed |
| WO-2022155284-A1 | CRYSTALLINE BUFOTENIDINE COMPOUNDS | CAAMTECH, INC. (US) | 2022-07-21 | — | — | WO | disclosed |
| EP-4017859-A1 | ALKYL QUARTERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, LLC (US) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021226041-A1 | CRYSTALLINE DIMETHYL TRYPTAMINE ANALOGUES | CAAMTECH, INC. (US) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021041407-A1 | ALKYL QUARTERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | CAAMTECH LLC (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-3487482-A1 | NEW CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME | Ebbu Inc. (US) | 2019-05-29 | — | — | EP | disclosed |
| WO-2018022669-A1 | NEW CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME | Ebbu, LLC (US) | 2018-02-01 | — | — | WO | disclosed |
| EP-3261629-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL | Ebbu, LLC (US) | 2018-01-03 | — | — | EP | disclosed |
| WO-2016138505-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL | Ebbu, LLC (US) | 2016-09-01 | — | — | WO | disclosed |
| EP-0924198-B1 | 3-Mercapto-2-alkyl-alkan-1-ols and their use as perfuming and flavouring agents | DRAGOCO GERBERDING CO AG (DE) | 2002-01-23 | — | — | EP | disclosed |